Lutter Briefs House Subcommittee on FDA's Anti-Counterfeiting Action Plan

Randall W. Lutter, Ph.D., FDA's Associate Commissioner for Policy and Planning, on July 11 addressed the House Committee on Government Reform's Subcommittee on Criminal Justice, Drug Policy, and Human Resources. He reported on the progress — and lack thereof — that FDA and industry have made toward the goals outlined in the Agency's "Combatting Counterfeit Drugs" report.

If you are not automatically redirected, follow this link:

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments